Clinical Trials Logo
  1. Home
  2. Defect of Articular Cartilage
  3. NCT01626677

Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect

Degenerative Osteoarthritis Clinical Trial

Official title:
Long Term Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee

Clinical Trial Summary

This is a long term follow-up study to investigate the safety and efficacy of CARTISTEM®, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects who participated in and completed the Phase III trial (NCT01041001) will be tracked until the 60 month post-treatment timepoint.

Clinical Trial Description

This long term follow-up study is performed to assess the long-term safety and efficacy of CARTISTEM®, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture. Subjects, who were either administered CARTISTEM or treated with conventional microfracture in the primary phase III study (NCT01041001), will be further observed using various subjective knee assessments and MRI T2 mapping until the 60 month post-treatment timepoint. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01626677
Study type Interventional
Source Medipost Co Ltd.
Contact
Status Completed
Phase Phase 3
Start date June 2012
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Active, not recruiting NCT03203330 - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee Phase 3
Not yet recruiting NCT05276011 - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis Phase 2
Active, not recruiting NCT03685110 - CoreHip - Post Market Clinical Follow-Up Study
Recruiting NCT05742763 - Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis Phase 1/Phase 2
Completed NCT02802085 - VEGA Prospective Kiel
Completed NCT01335243 - Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow Phase 2
Completed NCT02756702 - All Polyethylene Tibia-VEGA Kiel
Not yet recruiting NCT02776943 - UCMSC Transplantation in the Treatment of Cartilage Damage Phase 1/Phase 2
Completed NCT01413061 - Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft N/A
Completed NCT06254976 - Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis N/A
Recruiting NCT05427019 - Continuous Distal Adductor Canal Block With Periarticular Local Anesthetic Infiltration Versus Continuous Distal Adductor Canal Block Alone for Analgesia After Total Knee Arthroplasty N/A
Completed NCT03817632 - Orthopilot Elite Post-Market Clinical Follow-Up
Recruiting NCT02687399 - Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT) Phase 2/Phase 3
Recruiting NCT03849885 - Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty Phase 4
Completed NCT03442855 - Non-Interventional, Multicenter Bicontact® E PMCF Study
Active, not recruiting NCT03291470 - Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee Phase 3
Completed NCT05291130 - AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
Active, not recruiting NCT04255966 - Plasmafit® Revision Structan® Hip Endoprosthesis Cup